Physician profile
Loyd B High
NPI 1467422436
$913.44
in general payments reported to CMS, 2019-2025
8 companies · $29.70 in 2025
The $29.70 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21.67 · 2020: $419 · 2021: $52.97 · 2022: $56.57 · 2023: $226 · 2024: $108 · 2025: $29.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $314 · Education: $49.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $314.41 |
| Education | $49.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $480.37 | 2019-2021 | |
| Medtronic, INC. | $124.95 | 2023 | Argyle |
| Argon Medical Devices, INC. | $87.42 | 2022-2023 | Cleaner |
| Vifor Pharma, INC. | $83.13 | 2021-2023 | |
| Akebia Therapeutics INC | $49.22 | 2024 | Vafseo |
| W. L. Gore & Associates, INC. | $48.06 | 2024-2025 | Gore Viabahn Endoprosthesis With Heparin |
| Becton, Dickinson and Company | $25.45 | 2024 | Fluency Endovascular Stent Graft |
| Merit Medical Systems INC | $14.84 | 2025 | Centros Hemodialysis Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Loyd High listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.